Literature DB >> 7543684

Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity.

R A McDonald1, R P Matthews, R L Idzerda, G S McKnight.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) functions as a Cl- channel that becomes activated after phosphorylation by cAMP-dependent protein kinase (PKA). We demonstrate that PKA also plays a crucial role in maintaining basal expression of the CFTR gene in the human colon carcinoma cell line T84. Inhibition of PKA activity by expression of a dominant-negative regulatory subunit or treatment with the PKA-selective inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89) caused a complete suppression of CFTR gene expression without affecting other constitutively active genes. Basal expression of a 2.2-kb region of the CFTR promoter linked to a luciferase reporter gene (CFTR-luc) exhibited the same dependence on PKA. The ability of cAMP to induce CFTR over basal levels is cell-type specific. In T84 cells, both the endogenous CFTR gene and CFTR-luc exhibited only a modest inducibility (approximately 2-fold), whereas in the human choriocarcinoma cell line JEG-3, CFTR-luc could be induced at least 4-fold. A variant cAMP-response element is present at position -48 to -41 in the CFTR promoter, and mutation of this sequence blocks basal expression. We conclude that cAMP, acting through PKA, is an essential regulator of basal CFTR gene expression and may mediate an induction of CFTR in responsive cell types.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543684      PMCID: PMC41379          DOI: 10.1073/pnas.92.16.7560

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Regulation of transcription by cyclic AMP-dependent protein kinase.

Authors:  P L Mellon; C H Clegg; L A Correll; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Functional characterization of cAMP-binding mutations in type I protein kinase.

Authors:  L A Correll; T A Woodford; J D Corbin; P L Mellon; G S McKnight
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

3.  A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription.

Authors:  R N Day; J A Walder; R A Maurer
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

4.  (Dys)regulation of epithelial chloride channels.

Authors:  H R de Jonge; N van den Berghe; B C Tilly; M Kansen; J Bijman
Journal:  Biochem Soc Trans       Date:  1989-10       Impact factor: 5.407

5.  Plasmids encoding PKI(1-31), a specific inhibitor of cAMP-stimulated gene expression, inhibit the basal transcriptional activity of some but not all cAMP-regulated DNA response elements in JEG-3 cells.

Authors:  J R Grove; P J Deutsch; D J Price; J F Habener; J Avruch
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

8.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Authors:  T Chijiwa; A Mishima; M Hagiwara; M Sano; K Hayashi; T Inoue; K Naito; T Toshioka; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

9.  A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.

Authors:  R L Medcalf; M Rüegg; W D Schleuning
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

10.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

View more
  22 in total

1.  Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

Authors:  R E Ellsworth; D C Jamison; J W Touchman; S L Chissoe; V V Braden Maduro; G G Bouffard; N L Dietrich; S M Beckstrom-Sternberg; L M Iyer; L A Weintraub; M Cotton; L Courtney; J Edwards; R Maupin; P Ozersky; T Rohlfing; P Wohldmann; T Miner; K Kemp; J Kramer; I Korf; K Pepin; L Antonacci-Fulton; R S Fulton; P Minx; L W Hillier; R K Wilson; R H Waterston; W Miller; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.

Authors:  S Vuillaumier; I Dixmeras; H Messaï; C Lapouméroulie; D Lallemand; J Gekas; F F Chehab; C Perret; J Elion; E Denamur
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Genomic approaches for the discovery of CFTR regulatory elements.

Authors:  Christopher J Ott; Ann Harris
Journal:  Transcription       Date:  2011 Jan-Feb

4.  Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism.

Authors:  Jérémie Roux; Michel Carles; Hidefumi Koh; Arnaud Goolaerts; Michael T Ganter; Brian B Chesebro; Marybeth Howard; Benjamin T Houseman; Walter Finkbeiner; Kevan M Shokat; Agnès C Paquet; Michael A Matthay; Jean-François Pittet
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

5.  A balance between activating and repressive histone modifications regulates cystic fibrosis transmembrane conductance regulator (CFTR) expression in vivo.

Authors:  Anne Bergougnoux; Isabelle Rivals; Alessandro Liquori; Caroline Raynal; Jessica Varilh; Milena Magalhães; Marie-José Perez; Nicole Bigi; Marie Des Georges; Raphaël Chiron; Ahmed Saad Squalli-Houssaini; Mireille Claustres; Albertina De Sario
Journal:  Epigenetics       Date:  2014-04-29       Impact factor: 4.528

Review 6.  Mitigation of chlorine lung injury by increasing cyclic AMP levels.

Authors:  Gary W Hoyle
Journal:  Proc Am Thorac Soc       Date:  2010-07

7.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

8.  HNF1alpha is involved in tissue-specific regulation of CFTR gene expression.

Authors:  Nathalie Mouchel; Sytse A Henstra; Victoria A McCarthy; Sarah H Williams; Marios Phylactides; Ann Harris
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

9.  Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene.

Authors:  Nele Gheldof; Emily M Smith; Tomoko M Tabuchi; Christoph M Koch; Ian Dunham; John A Stamatoyannopoulos; Job Dekker
Journal:  Nucleic Acids Res       Date:  2010-03-31       Impact factor: 16.971

10.  Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter.

Authors:  Marzena A Lewandowska; Fabricio F Costa; Jared M Bischof; Sarah H Williams; Marcelo B Soares; Ann Harris
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-23       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.